SPDR S&P Biotech shares owned by Wiley Bros.-aintree Capital
Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by Wiley Bros.-aintree Capital
from 13F filings
Historical chart of Wiley Bros.-aintree Capital investment in SPDR S&P Biotech
Tip: Access up to 7 years of quarterly data
All positions including SPDR S&P Biotech held by Wiley Bros.-aintree Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in SPDR S&P Biotech by Wiley Bros.-aintree Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $6.5M | 51k | 127.81 |
| 2025-12-31 | $4.3M | 35k | 121.93 |
| 2025-09-30 | $2.6M | 25k | 100.99 |
| 2025-06-30 | $2.0M | 24k | 82.93 |
| 2025-03-31 | $1.5M | 18k | 84.40 |
| 2024-12-31 | $1.7M | 18k | 92.31 |
| 2024-09-30 | $659k | 6.7k | 98.77 |
| 2024-06-30 | $551k | 5.9k | 92.71 |
| 2024-03-31 | $520k | 5.5k | 94.89 |
| 2023-12-31 | $489k | 5.5k | 89.29 |
| 2023-09-30 | $400k | 5.5k | 73.02 |
| 2023-06-30 | $549k | 6.6k | 83.20 |
| 2023-03-31 | $503k | 6.6k | 76.21 |
| 2022-12-31 | $548k | 6.6k | 83.00 |
| 2022-09-30 | $532k | 6.7k | 79.37 |
| 2022-06-30 | $509k | 6.8k | 74.33 |
| 2022-03-31 | $573k | 6.4k | 89.88 |
| 2021-12-31 | $719k | 6.4k | 111.91 |
| 2021-09-30 | $745k | 5.9k | 125.74 |
| 2021-06-30 | $817k | 6.0k | 135.38 |
| 2021-03-31 | $789k | 5.8k | 135.68 |
| 2020-12-31 | $819k | 5.8k | 140.84 |
| 2020-09-30 | $673k | 6.0k | 111.42 |
| 2020-06-30 | $676k | 6.0k | 111.92 |
| 2020-03-31 | $483k | 6.2k | 77.40 |
| 2019-12-31 | $593k | 6.2k | 95.03 |
| 2019-09-30 | $497k | 5.2k | 95.95 |
| 2019-06-30 | $580k | 6.6k | 87.68 |
| 2019-03-31 | $599k | 6.6k | 90.55 |
| 2018-12-31 | $461k | 6.6k | 70.33 |
More positions owned by Wiley Bros.-aintree Capital
View all positions for Wiley Bros.-aintree Capital